Corpus Intelligence DCF — ADVENTHEALTH OTTAWA 2026-04-26 02:15 UTC
DCF — ADVENTHEALTH OTTAWA
Enterprise Value: $-48.3M
🛡️ Public data only — no PHI permitted on this instance.
$-48.3M
Enterprise Value
$-16.1M
PV of Cash Flows
$-32.2M
PV of Terminal Value
$-51.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth

Cash Flow Projections

PROJ
YearRevenueEBITDAMarginFCFPV(FCF)
Year 1$55.0M$-2.6M-5.0%$-4.9M$-4.4M
Year 2$56.6M$-2.1M-4.0%$-4.5M$-3.7M
Year 3$58.3M$-1.5M-3.0%$-4.0M$-3.0M
Year 4$60.1M$-1.3M-2.0%$-3.8M$-2.6M
Year 5$61.9M$-1.2M-2.0%$-3.8M$-2.4M

Interpretation

INT

At a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-48.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.

Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.

Assumptions

ASSM
revenue base$53.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05150095255762547
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5